Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.87 USD | -5.55% |
|
+10.57% | +43.74% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.74% | 2.04B | |
+48.75% | 57.87B | |
+41.65% | 40.25B | |
-6.88% | 39.94B | |
-5.96% | 28.54B | |
+12.66% | 26.4B | |
-20.09% | 19.33B | |
+31.25% | 12.4B | |
-0.25% | 12.23B | |
+25.13% | 12.2B |
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- Capital One Starts Protagonist Therapeutics With Overweight Rating, $32 Price Target